Nucleo-Vir Therapeutics India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 93.00 K
- Company Age 5 Months 13 Days
About Nucleo-Vir Therapeutics India
Nucleo-Vir Therapeutics India Private Limited (NTIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2024 ( five months 13 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 93.00 K , as per Ministry of Corporate Affairs (MCA) records.
Yogesh Ostwal and Sarika Bamb serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U72100PN2024PTC234244
- Company No.
234244
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Nucleo-Vir Therapeutics India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Ostwal  | Director | 10-Sep-2024 | Current |
| Sarika Bamb | Director | 10-Sep-2024 | Current |
Financial Performance of Nucleo-Vir Therapeutics India.
Enhance accessibility to Nucleo-Vir Therapeutics India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nucleo-Vir Therapeutics India?
Unlock access to Nucleo-Vir Therapeutics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nucleo-Vir Therapeutics India?
Unlock and access historical data on people associated with Nucleo-Vir Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleo-Vir Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleo-Vir Therapeutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.